Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
CSL Behring LLC, a global leader in biopharmaceuticals, is headquartered in the United States and operates extensively across North America, Europe, and Asia-Pacific. Founded in 1904, the company has established itself in the industry by focusing on innovative therapies for rare and serious medical conditions, particularly in immunology, haematology, and respiratory care.
CSL Behring is renowned for its core products, including immunoglobulins and clotting factor therapies, which are distinguished by their high quality and efficacy. The company’s commitment to research and development has led to significant advancements in patient care, solidifying its position as a trusted provider in the biopharmaceutical market. With a strong emphasis on patient-centric solutions, CSL Behring continues to achieve notable milestones, enhancing the lives of patients worldwide.
+2 vs industry average
CSL Behring LLC’s score of 44 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for CSL Behring LLC yet.
CSL Behring LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of CSL Limited, which influences its climate commitments and emissions reporting.
CSL Limited, the parent organisation, has set various climate initiatives that cascade down to CSL Behring. However, specific reduction targets or achievements for CSL Behring are not detailed in the available data. The company is part of broader sustainability efforts, including participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from CSL Limited.
While CSL Behring LLC has not disclosed its own emissions figures, it is aligned with the climate strategies of its parent company, which aims to address carbon emissions comprehensively across its operations. The absence of specific emissions data highlights the need for ongoing transparency and commitment to climate action within the organisation.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for CSL Behring LLC yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for CSL Behring LLC yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more